Destia, the leading French provider of home care services for seniors and people with disabilities, has attracted new investors to support the group’s next phase of growth in France and across Europe. New investors Bpifrance, Three Hills, Turenne Santé and VYV, join new historical shareholders – Siparex ETI (majority shareholder since 2021), alongside BNP Paribas Développement, MACSF, Azulis, Après demain and Crédit Agricole – which are reinvesting.
“This change in our shareholding structure marks a new stage of growth for Destia,” said Xavier Mura, Destia’s founding president. “It brings together new partners and historical shareholders, faithful to our vision, with a common ambition: to build the future of home care by placing employees at the heart of the company’s project.”
Founded in 2006 by Mura, Destia has a network of 180 agencies in France and Europe and offers a complete range of services promoting autonomy and well-being at home. Destia also offers inclusive housing solutions, has developed and a training activity dedicated to the home help professions.
Since the entry of Siparex ETI into the shareholder structure, Destia’s turnover has increased from €100m to more than €250m in 2025, driven by organic growth and more than 40 acquisitions which saw it establish a presence in Spain, Ireland, Germany and Switzerland.
“Since 2021, Xavier Mura and his teams have demonstrated a remarkable ability to transform the group, to multiply acquisitions with discipline and to open new markets in Europe, while asserting a singular identity,” according to Guillaume Rebaudet and Thibaud de Portzamparc, partners of Siparex ETI. “This transaction is a new strategic step in the continuation of Destia’s development path.”
Stakeholders:
Historical investors: Xavier Mura; Siparex (Guillaume Rebaudet, Thibaud de Portzamparc, Marine Vernay, Sixte de Labarre); MACSF (Roger Caniard); BNP Paribas Development (Frédéric Connault, Sophie Hemond); Après demain (Benoit Junique, Julien Leclerc); Carvest (Cécile Ormerod, Ronan Auffret); Azulis (Astrid Cloarec); Mutuelles Impact (Nicolas Rose, Nadja Bresous Mehigan, Hugo Ben Grine)
New investors: Bpifrance (Benoist de Saint Lager, Pierre Monin, Wissal El Achgar, Amira Mnafek); Three Hills (Pauline Ammeux, Xavier Bayrou); Turenne Santé (Paul Chamoulaud, Grégory Dupas, Thaïs Baudeau); VYV (Guillaume Chatelet, Christèle Delye, Aurélien Bon, Arnaud Cornet)
Funding: Eurazeo (Nicolas Nedelec, Emmanuelle Tanguy, Mehdi Heikel)
Historical investor advisors:
Houlihan Lokey – M&A: (François Rivalland, Ludovic Tron, Bertrand Duquesne, Véran Berard-Quelin, Pierre May, Mathis Vernerey); Houlihan Lokey – Financing advisor: (Patrice Raulin, Gabriel Besnard); Nabarro Béraud Avocats: (Anthony Minzière, Jonathan Nabarro); Eight Advisory: (Sandrine Vouillon, Xavier Mesguich, Christophe Delas, Thomas Christophe).
VDD: Agilys Avocats (Baptiste Bellone, Karine Violeau, Alexis Le Douche, Carolle Thain-Navarro, Livia Cancilleri); Dentons (Julie Caussade, Julie Ragueneau)
Deal: Agilys (Baptiste Bellone, Karine Violeau, Sophie Auvergne, Alexis Le Douche, Carolle Thain-Navarro, Livia Cancilleri); Roland Berger – sales DD (Julien Gautier, Charles Colrat); Mayer Brown – founder and management advisors (Bernard Ayache, Grégoire Zeitoun, Bruno Erard, Kyllian Lancereau-Lignez); Komizo – DD ESG (Corentin Decouty, Julie Lefebvre)
New investor advisors:
CACIB – M&A (Samuel Knossow, Hugues Hauth); KPMG -BS DD (Antoine Bernabeu, Hassina Oudjane, Nicolas Le Fur, Xavier Houard, Florence Olivier, Albane Eglinger); FTI Consulting – political DD (Grégory Grellet, Estelle Forfert); Hogan Lovells (Stéphane Huten, Laura Medjoub, Guergana Zabounova, Alexander Premont); PWC (Pierre-Guillaume Sagnol, Yassine Ben Kraiem, Saad Houpert); Jeantet (Maxime Brotz, Maria Plakci, Pak Hang Li, Pauline Chastang); LEK (Jean-Guillaume Bayada, Serge Hovsepian, Andréa Isak)
Financing advice:
Mermoz (Martin Kyuchukov, Anne-Sophie Rama, Céline Chang)
